PRA023, AN ANTI-TL1A INHIBITORY ANTIBODY, REDUCED INFLAMMATORY AND FIBROSIS ASSOCIATED BIOMARKERS IN ULCERATIVE COLITIS PATIENTS WHO ACHIEVED CLINICAL REMISSION

Silvio Danese  ¹     Maria Abreu  ²     Yong Wang  ³     Heather Llewellyn  ³     Eleanor Dagostino  ³     Fadi Towfic  ³     Deanna Nguyen  ³     Brian G. Feagan  ⁴     Bruce E. Sands  ⁵     Florian Rieder  ⁶     Stephan Targan  ⁷     Ernesto Munoz  ^7    
1 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milano, Italy
² University of Miami Miller School of Medicine, Miami, United States
³ Prometheus Biosciences, Inc., San Diego, United States
⁴ Western University, London, Canada
⁵ Icahn School of Medicine at Mount Sinai, New York, United States
⁶ Cleveland Clinic Foundation, Cleveland, United States
⁷ F. Widjaja IBD Institute, Cedars Sinai Medical Center, Los Angeles, United States

Topic
IBD

Session
Traffic control in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)